The Effect of Neoadjuvant vs Adjuvant Chemotherapy on Final Outcome of Patients with Triple Negative Breast Cancer

Background: Triple negative breast cancer (TNBC) accounts for about 10% to 20% of breast cancers, does not respond to endocrine treatment, and is more aggressive. Two chemotherapy methods suggested include neoadjuvant chemotherapy (NAC), performed before surgery, and adjuvant chemotherapy (AC), perf...

Descripción completa

Detalles Bibliográficos
Autores principales: Dabbagh, Najmeh, Riazi, Hooman, Khayamzadeh, Maryam, Negahi, Alireza, Akbari, Mahnaz, Akbari, Mohammad Esmail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448446/
https://www.ncbi.nlm.nih.gov/pubmed/36128267
http://dx.doi.org/10.47176/mjiri.36.61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448446/
https://www.ncbi.nlm.nih.gov/pubmed/36128267
http://dx.doi.org/10.47176/mjiri.36.61

Ejemplares similares